Background illustration for clinical trials search

Paid Clinical Trials Bellevue

Discover 611 paid clinical trials in Bellevue, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease

for
Peripheral Arterial Disease, Painful Diabetic Neuropathy,
Location: Omaha NE
Sponsor: University of Nebraska

Sex: All

Age: 19 - 70+

Code: NCT06480786

Recruiting

The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)

for
Infection, Acute Kidney Injury, Sepsis
Location: Omaha NE, Morgantown WV, Winston-Salem NC,
Sponsor: Bassett Healthcare

Sex: All

Age: 18+

Code: NCT07556107

Phase 4, Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Omaha NE, Merriam KS, Kansas City MO, Lenexa KS,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase 2, Phase 3, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Omaha NE, Des Moines IA, Kansas City MO, Wichita KS,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Omaha NE, Des Moines IA, Kansas City MO, Sioux Falls SD,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

for
Small Cell Lung Cancer (SCLC),
Location: Omaha NE, Kansas City MO, Memphis TN, Shreveport LA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07472517

Phase 3, Recruiting

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

for
Warm Autoimmune Hemolytic Anemia (WAIHA),
Location: Omaha NE, Rochester MN, Boston MA
Sponsor: CRISPR Therapeutics AG

Sex: All

Age: 18+

Code: NCT07549698

Phase 1, Phase 2, Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

for
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma,
Location: Omaha NE, Waukee IA, Des Moines IA, Clive IA, Ankeny IA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06958328

Phase 3, Recruiting

NORM-HF Pivotal Study

for
Heart Failure, NYHA Class III Heart Failure,
Location: Omaha NE, Kansas City MO, Sioux Falls SD, Tulsa OK,
Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)

Sex: All

Age: 18+

Code: NCT07574593

Recruiting

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

for
Focal Seizure, Epilepsy, Focal Epilepsy
Location: Omaha NE, Bentonville AR, Chicago IL,
Sponsor: Rapport Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT07594119

Phase 3, Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Omaha NE, Kansas City MO, Iowa City IA, Rochester MN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06997497

Phase 3, Recruiting

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

for
Acute Myeloid Leukaemia (AML)
Location: Omaha NE, Birmingham AL, Cleveland OH, Augusta GA,
Sponsor: Moleculin Biotech, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06788756

Phase 2, Phase 3, Recruiting

Randomization of Single vs Multiple Arterial Grafts

for
Coronary Artery Disease, Heart Diseases
Location: Omaha NE, Lincoln NE, Boulder CO, Winnipeg,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18 - 70

Code: NCT03217006

Recruiting

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension (PAH)
Location: Omaha NE, Aurora CO, Cincinnati OH, Boston MA
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318597

Phase 2, Recruiting

ERAS Protocols in Breast Conserving Surgery

for
Breast Cancer, Postoperative Recovery
Location: Omaha NE
Sponsor: University of Nebraska

Sex: All

Age: 19+

Code: NCT06938581

Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Omaha NE, Rochester MN, Milwaukee WI, Nashville TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876649

Recruiting

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Omaha NE, Iowa City IA, Rochester MN, St Louis MO,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT07096778

Phase 2, Recruiting

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

for
Heart Transplant, Heart Failure, Transplant; Failure, Heart
Location: Omaha NE, St Louis MO, Chicago IL, Dallas TX,
Sponsor: XVIVO Perfusion

Sex: All

Age: 18+

Code: NCT06895070

Recruiting

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Omaha NE, Rochester MN, Milwaukee WI, Chicago IL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876662

Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Omaha NE, Des Moines IA, Kansas City MO, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting